Caymus Equity Partners LLC (“Caymus Equity”) has announced that its portfolio company, Medical Laboratory Diagnostics, LLC (“MedLabs” or the “Company”), has acquired Mercy Diagnostics, Inc. (“Mercy”) located in Mount Laurel, NJ. Mercy provides a full spectrum of diagnostic services including routine and esoteric clinical testing, cytology, histology, and microbiology with a full array of interfacing possibilities with the patients’ PMS/EMR.
The transaction represents the Company’s first strategic acquisition since Caymus Equity partnered with PNC Mezzanine Capital and management to lead a majority recapitalization of MedLabs in March 2018.
The transaction closed on April 24, 2019. To learn more about MedLabs, visit www.medlabdx.com